scispace - formally typeset
R

Rahul Shekhar

Researcher at University of New Mexico

Publications -  56
Citations -  1163

Rahul Shekhar is an academic researcher from University of New Mexico. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 30 publications receiving 244 citations.

Papers
More filters
Journal ArticleDOI

COVID-19 Vaccine Acceptance among Health Care Workers in the United States.

TL;DR: In this article, the authors conducted a cross-sectional study to assess the attitude of healthcare workers toward COVID-19 vaccination and found that 36% of respondents were willing to take the vaccine as soon as it became available while 56% were not sure or would wait to review more data.
Posted ContentDOI

COVID-19 Vaccine Acceptance Among Health Care Workers in the United States

TL;DR: In this paper, the authors conducted a cross-sectional study to assess the attitude of healthcare workers toward COVID-19 vaccination and found that 36% of respondents were willing to take the vaccine as soon as it became available while 56% were not sure or would wait to review more data.
Journal ArticleDOI

The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.

TL;DR: In this paper, the authors summarized the relevant scientific literature about neuro-PASC and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection.
Journal ArticleDOI

COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers.

TL;DR: In this paper, the authors re-examine the attitude toward COVID-19 vaccines among healthcare workers several months after the vaccines have been made widely available, finding that only 7.9% of respondents were hesitant to take the first or second dose of the vaccine.
Journal ArticleDOI

COVID-19 Vaccine Booster: To Boost or Not to Boost.

TL;DR: In this article, the authors developed usage guidelines for COVID-19 vaccine booster doses while considering the dangers of potential waning immunity and new viral strains and prioritizing vulnerable populations everywhere, including those living in lower-income countries.